HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Diisopropylethylamine → 1-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-N,N-dimethylpiperidine-4-sulfonamide

HRID 1619873
Notes
Print preview

Reaction equation

HRID 1619873 reaction equation
[CH3:1][N:2]([CH3:22])[S:3]([CH:6]1[CH2:11][CH2:10][N:9]([C:12](OCC2C=CC=CC=2)=O)[CH2:8][CH2:7]1)(=[O:5])=[O:4].ClC1[N:29]=[C:28]([N:30]2[CH2:35][CH2:34][O:33][CH2:32][CH2:31]2)[N:27]=[C:26]([N:36]2[C:40]3[CH:41]=[CH:42][CH:43]=[C:44]([O:45][CH3:46])[C:39]=3[N:38]=[C:37]2[CH:47]([F:49])[F:48])[N:25]=1.CCN(C(C)C)C(C)C>CO.C1COCC1.[Pd]>[F:49][CH:47]([F:48])[C:37]1[N:36]([C:26]2[N:27]=[C:28]([N:30]3[CH2:31][CH2:32][O:33][CH2:34][CH2:35]3)[N:29]=[C:12]([N:9]3[CH2:8][CH2:7][CH:6]([S:3]([N:2]([CH3:1])[CH3:22])(=[O:4])=[O:5])[CH2:11][CH2:10]3)[N:25]=2)[C:40]2[CH:41]=[CH:42][CH:43]=[C:44]([O:45][CH3:46])[C:39]=2[N:38]=1
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

7

Reactant 3

HCID 81531DiisopropylethylamineHCID 534881021-[4-Chloro-6-(morpholin-4-yl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-4-methoxy-1H-benzimidazoleHCID 53587548Benzyl 4-[(dimethylamino)sulfonyl]-1-piperidinecarboxylate

Product 1

HCID 469175741-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-N,N-dimethylpiperidine-4-sulfonamideYield 86%

Reagents, catalysts & solvents

3
HCID 23938PalladiumCatalystHCID 887MethanolSolventHCID 8028TetrahydrofuranSolvent

Procedure

The above carbamate was hydrogenated over 5% Pd on carbon in MeOH. After removal of the solvent, the residue was combined with 0.19 g (0.48 mmol) 1-[4-chloro-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-4-methoxy-1H-benzimidazole (Example 2) and DIPEA in THF. The mixture was heated under reflux for 30 min and the solvent was removed. After dilution with water, the resulting solid was collected and dried. Chromatography on silica, eluting with CH2Cl2/EtOAc (93:7), gave 0.227 g (86% yield) of 1-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-N,N-dimethyl-4-piperidinesulfonamide: mp (MeOH) 260-264° C.; 1H NMR (CDCl3) δ 7.88 (dd, J=8.4, 0.6 Hz, 1H), 7.46 (t, JHF=53.5 Hz, 1H), 7.35 (t, J=7.7 Hz, 1H), 6.81 (d, J=7.7 Hz, 1H), 4.91 (br d, J=13.5 Hz, 2H), 4.05 (s, 3H), 3.88 (m, 4H), 3.78 (m, 4H), 3.27 (tt, J=11.8, 3.8 Hz, 1H), 2.95 (s, 6H), 2.17 (dd, J=12.7, 2.2 Hz, 2H), 1.85 (dq, J=12.6, 4.2 Hz, 2H); Anal. Calcd. for C23H30F2N8O4S: C, 50.0; H, 5.5; N, 20.3. Found: C, 49.9; H, 5.5; N, 20.4%.

Workup

  1. customAfter removal of the solvent
  2. temperatureThe mixture was heated
  3. temperatureunder reflux for 30 min
  4. customthe solvent was removed
  5. customAfter dilution with water, the resulting solid was collected
  6. customdried
  7. washChromatography on silica, eluting with CH2Cl2/EtOAc (93:7)

Sources & evidence

ORD record
ord-85badc7a631343e8a7e3299c868a4543
Source dataset
uspto-grants-2014_07
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08772287B2

Reaction notes

Loading…

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes